検索キーワード： 薬理学

日本で最もたくさんのワクチンを商品として販売してきた製薬会社。その会社で若手のホープとして期待を集めていた影山晃大氏が、26歳で突然の死を遂げた。原因は、2回目のコロナワクチン接種。

妊娠中毒症、切迫早産、切迫流産のママがあなたのパートナーなら聴いておくとママの気持ちを理解できます。

The authors of the best-selling Bold and The Rise of Superman explore altered states of consciousness and how they can ignite passion, fuel creativity, and accelerate problem solving, in this groundbreaking book in the vein of Daniel Pink's Drive and Charles Duhigg's Smarter Faster Better.

These drugs are about to change our world, for better and for worse. Everybody needs to understand how they work – scientifically, emotionally and culturally. Magic Pill is an essential guide to the revolution that has already begun – and which one leading expert argues could be as transformative as the invention of the smartphone.

Every catastrophe has a beginning. For the opioid crisis in America, the seed was a drug called OxyContin. First hailed as a miracle drug for severe pain in the early 1990s, OxyContin went on to ignite a plague of addiction and death across America. Equal parts crime thriller, medical detective story and business exposé, Pain Killer is the origin story of the opioid crisis, a hard-hitting look at how a supposed wonder drug became the trigger for a national tragedy.

Reveals the truth behind the controversial issue of vaccine-related injuries. Proponents declare that vaccines have saved millions of lives. Critics claim that the success is overstated and that vaccines may even be dangerous. Many consider mandatory vaccinations a violation of individual rights or religious principles. Many in public health argue that vaccine mandates are critical and justified and that antivaccination sentiment has resulted in outbreaks of preventable childhood illnesses.

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

The 20th century saw a remarkable upsurge of research on drugs, with major advances in the treatment of bacterial and viral infections, heart disease, stomach ulcers, cancer, and metal illnesses. These, along with the introduction of the oral contraceptive, have altered all of our lives. There has also been an increase in the recreational use and abuse of drugs in the Western world. This Very Short Introduction, in its second edition, gives a nontechnical account of how drugs work in the body.

Almost daily, headlines announce newly discovered links between cancers and their genetic causes. Science journalist Jessica Wapner vividly relates the backstory behind those headlines, reconstructing the crucial breakthroughs, explaining the science behind them, and giving due to the dozens of researchers, doctors, and patients whose curiosity and determination restored the promise of a future to the more than 50,000 people diagnosed each year with chronic myeloid leukemia (CML).

Medicine has become inhuman, to disastrous effect. The doctor-patient relationship - the heart of medicine - is broken: doctors are too distracted and overwhelmed to truly connect with their patients, and medical errors and misdiagnoses abound. In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help. AI has the potential to transform everything doctors do, from notetaking and medical scans to diagnosis and treatment, greatly cutting down the cost of medicine and reducing human mortality.

From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization - The Jungle for pharmaceuticals.

In this explosive expose of the drug companies and how they are ripping us off, Marcia Angell, M.D., a doctor, medical journalist, and a former editor of the respected New England Journal of Medicine, reveals the many ways in which the pharmaceutical industry has moved away from its original purpose of finding and producing useful new drugs.

This is perhaps one of the best-loved of all journals. William Wordsworth's sister, Dorothy, began it in May 1800 and resolved to keep it for a short time. She continued it for nearly three years. In it, she brought the Dove Cottage years to vivid and intimate life. She noted the walks and weather, the friends, country neighbours, and travellers on the roads. She set down accounts of the garden, of Wordsworth's marriage, their concern for Coleridge, and the composition of Wordsworth's poetry.

When it comes to mastering vast amounts of information quickly, flashcards have proven to be an incredibly effective learning tool. Studies have shown that their ability to reinforce memory through repetition and active recall makes them indispensable for students facing challenging exams. Whether you're preparing for a crucial exam or seeking to solidify your drug knowledge, this guide offers an accessible and efficient way to review the top 200 drugs, tailored to your specific educational needs.

Can a story written almost 200 years ago help us understand the modern world? In Searching for Goldilocks, Dr. Matt Kresl explores the search for “just right” within and all around us. Basing his discussion on the Goldilocks Principle, a reference to the children’s fairytale Goldilocks and the Three Bears, Dr. Kresl focuses on how science, spirituality, and storytelling form a launching point to explore the concept of “just right” in everyday life.

For over a decade, Cytokinetics, a biopharmaceutical company, has been at the forefront of the fight to discover new potential therapies for people living with ALS. Ultimately, the company was unsuccessful in bringing forward a new medicine for people with ALS, and while some might see this as a story ending in failure, it is anything but. This book shares the company’s journey—inspired and guided by the extraordinary members of the greater ALS community.

The newest class of weight loss drugs (GLP-1s) are complete game-changers in their potential to reverse obesity and its related diseases, with nearly 50% of Americans qualifying for the use of these drugs. Already 1 in 8 Americans say they’ve tried a GLP-1 medication—but with many acquiring their prescription from online pharmacies, med spas, and general practitioners, they face a huge gap between trying the drug and achieving their health goals with it long-term. That’s where The Ozempic Revolution comes in.

Each day we are exposed to a myriad of natural and human-made chemicals in our food, drinking water, air, soil, at home or at the workplace-pesticide residues, food additives, drugs, household products-but how can we gauge the human health risk posed by these chemicals? Should we believe the somber headlines that depict a serious threat for humans and the environment, or should we follow the reassuring voices of others who claim that the angst is totally unfounded?

Dr. Peter Patterson understands that using antibiotics “just in case” is ingrained in our culture. Everyone, from health care professionals to patients and their advocates, shares the blame—but we cannot afford to let the practice continue. Becoming Good Stewards of Antibiotics is a call to action to restore and preserve antibiotic effectiveness.

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them.